x |
| EBITDA Improves 31% for Salix Pharmaceuticals |
|
Stock Quote: (NasdaqNM:SLXP) |
| 11/18/2009 |
|
| 26.97 |
-0.13 |
-0.48% |
368,050 |
|
| EBITDA Improves 31% for Salix Pharmaceuticals |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 18, 2009-Ebitda News reports that negative EBITDA for Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) for its twelve months ended September 30, 2009 was $(28,338,000), a 31% improvemen ... read full story |
|
|
|